109683 ⎘
dsDNA viruses; Details; Adenoviridae; Mastadenovirus, e.g. human or simian adenoviruses Use of virus, viral particle or viral elements as a vector
Sub-classes:TUMOR-SELECTIVE E1A AND E1B MUTANTS
#2EGFR VACCINE CASSETTES
#3METHODS AND COMPOSITIONS FOR REGENERATING HAIR CELLS AND/OR SUPPORTING CELLS
#4FORMULATIONS FOR SMALL INTESTINAL DELIVERY OF RSV AND NOROVIRUS ANTIGENS
#5VIRAL VECTOR AND RECOMBINANT SIMIAN ADENOVIRUS
#6Methods for the treatment of COVID-19 comprising administering replication-defective adenoviruses encoding the SARS-CoV-2 spike glycoprotein and modified nucleocapsid protein
#7Tumor-selective E1a and E1b mutants
#8Process for Making Adenoassociated Viral Vectors
#9Formulations for small intestinal delivery of RSV and norovirus antigens
#10COMBINATION OF A TLR7 MODULATING COMPOUND AND AN HIV VACCINE
#11PHARMACEUTICAL COMPOSITIONS TO ENHANCE PHAGOCYTOSIS WITHOUT INFLAMMATION
#12Chimpanzee adenoviral vector-based filovirus vaccines
#13Method of inducing immunity against SARS-CoV-2 using spike and nucleocapsid-ETSD immunogens delivered by RNA and replication-defective adenoviruses
#14Enhancing health in mammals using telomerase reverse transcriptase gene therapy
#15Cancer vaccines and methods of producing and using same
#16Replication-defective adenoviruses comprising nucleic acids encoding SARS-CoV-2 s glycoprotein and modified N protein comprising an endosomal targeting sequence
#17Tumor-selective E1A and E1B mutants
#18Recombinant human replication-deficient adenovirus comprising a modified nucleic acid encoding the Marburg virus envelope glycoprotein
#19Methods and compositions for regenerating hair cells and/or supporting cells
#20Enhancing health in mammals using telomerase reverse transcriptase gene therapy
#21Glaucoma treatment
#22Simian adenoviruses SAdV-43, -45, -46, -47, -48, -49, and -50, and uses thereof
#23CANCER VACCINES AND METHODS OF PRODUCING AND USING SAME
#24CRYSTALLINE DIACYLHYDRAZINE AND THE USE THEREOF
#25Tumor-selective E1a and E1b mutants
#26Enhancing health in mammals using telomerase reverse transcriptase gene therapy
#27Isolating traffic-enhancing mutants of drug delivery protein
#28Methods for inducing an immune response
#29Synthetic adenoviruses with tropism to damaged tissue for use in promoting wound repair and tissue regeneration
#30Formulations for small intestinal delivery of RSV and norovirus antigens
#31Simian adenoviruses SAdV-43, -45, -46, -47, -48, -49, and -50, and uses thereof
#32Human adenovirus serotype 5 vectors containing E1 and E2B deletions encoding the ebola virus glycoprotein
#33MODIFICATION OF RECOMBINANT ADENOVIRUS WITH IMMUNOGENIC PLASMODIUM CIRCUMSPOROZOITE PROTEIN EPITOPES
#34Crystalline diacylhydrazine and the use thereof
#35Enhancing health in mammals using telomerase reverse transcriptase gene therapy
#36Method of making adenovirus and corresponding plasmids
#37Treatment and prevention of malaria
#38Glaucoma treatment
#39Crimean-congo haemorrhagic fever virus antigenic composition
#40Enhancing health in mammals using telomerase reverse transcriptase gene therapy
#41Angiogenic conditioning to enhance cardiac cellular reprogramming of fibroblasts of the infarcted myocardium
#42Isolating traffic-enhancing mutants of drug delivery protein
#43Simian adenoviruses SAdV-43, -45, -46, -47, -48, -49, and -50, and uses thereof
#44Crystalline diacylhydrazine and the use thereof
#45Method of treating diabetes by a CTRP12 polypeptide
#46Use of VEGF in the Treatment of Retarded Fetal Growth in Pregnancy
#47Modification of recombinant adenovirus with immunogenic plasmodium circumsporozoite protein epitopes
#48THERAPEUTIC REGIMEN FOR TREATING CANCER
#49Tumor selective E1a and E1b mutants
#50Simian adenoviruses SAdV-43, -45, -46, -47, -48, -49, and -50 and uses thereof
#51THERAPEUTIC REGIMEN FOR TREATING CANCER
#52Use of the adenoviral E2 late promoter
#53THERAPEUTIC REGIMEN FOR TREATING CANCER
#54Use of the adenoviral E2 late promoter